These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 20151181

  • 1. Understanding the behavior of amorphous pharmaceutical systems during dissolution.
    Alonzo DE, Zhang GG, Zhou D, Gao Y, Taylor LS.
    Pharm Res; 2010 Apr; 27(4):608-18. PubMed ID: 20151181
    [Abstract] [Full Text] [Related]

  • 2. Dissolution and precipitation behavior of amorphous solid dispersions.
    Alonzo DE, Gao Y, Zhou D, Mo H, Zhang GGZ, Taylor LS.
    J Pharm Sci; 2011 Aug; 100(8):3316-3331. PubMed ID: 21607951
    [Abstract] [Full Text] [Related]

  • 3. Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine.
    Konno H, Handa T, Alonzo DE, Taylor LS.
    Eur J Pharm Biopharm; 2008 Oct; 70(2):493-9. PubMed ID: 18577451
    [Abstract] [Full Text] [Related]

  • 4. Crystallization of amorphous indomethacin during dissolution: effect of processing and annealing.
    Greco K, Bogner R.
    Mol Pharm; 2010 Oct 04; 7(5):1406-18. PubMed ID: 20459092
    [Abstract] [Full Text] [Related]

  • 5. Real time Raman imaging to understand dissolution performance of amorphous solid dispersions.
    Tres F, Treacher K, Booth J, Hughes LP, Wren SA, Aylott JW, Burley JC.
    J Control Release; 2014 Aug 28; 188():53-60. PubMed ID: 24910191
    [Abstract] [Full Text] [Related]

  • 6. The Influence of Cellulosic Polymer's Variables on Dissolution/Solubility of Amorphous Felodipine and Crystallization Inhibition from a Supersaturated State.
    Shi NQ, Jin Y, Zhang Y, Che XX, Xiao X, Cui GH, Chen YZ, Feng B, Li ZQ, Qi XR.
    AAPS PharmSciTech; 2018 Dec 17; 20(1):12. PubMed ID: 30560388
    [Abstract] [Full Text] [Related]

  • 7. [Study on the properties of felodipine solid dispersions prepared by different technologies].
    Shi NQ, Zhang H, Zhang Y, Feng B, Li ZQ, Qi XR.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec 18; 48(6):1067-1073. PubMed ID: 27987515
    [Abstract] [Full Text] [Related]

  • 8. Better understanding of dissolution behaviour of amorphous drugs by in situ solid-state analysis using Raman spectroscopy.
    Savolainen M, Kogermann K, Heinz A, Aaltonen J, Peltonen L, Strachan C, Yliruusi J.
    Eur J Pharm Biopharm; 2009 Jan 18; 71(1):71-9. PubMed ID: 18590816
    [Abstract] [Full Text] [Related]

  • 9. Impact of polymers on the crystallization and phase transition kinetics of amorphous nifedipine during dissolution in aqueous media.
    Raina SA, Alonzo DE, Zhang GG, Gao Y, Taylor LS.
    Mol Pharm; 2014 Oct 06; 11(10):3565-76. PubMed ID: 25185035
    [Abstract] [Full Text] [Related]

  • 10. Screen for Inhibitors of Crystal Growth to Identify Desirable Carriers for Amorphous Solid Dispersions Containing Felodipine.
    Fu J, Cui L, Yang C, Xiong H, Ren G, Ma X, Jing Q, Ren F.
    AAPS PharmSciTech; 2018 Apr 06; 19(3):1231-1242. PubMed ID: 29302871
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of polymers and media type on extending the dissolution of amorphous pioglitazone and inhibiting the recrystallization from a supersaturated state.
    Shi NQ, Yao J, Wang XL.
    Drug Dev Ind Pharm; 2014 Aug 06; 40(8):1112-22. PubMed ID: 23808528
    [Abstract] [Full Text] [Related]

  • 14. Effect of different preparation methods on the dissolution behaviour of amorphous indomethacin.
    Karmwar P, Graeser K, Gordon KC, Strachan CJ, Rades T.
    Eur J Pharm Biopharm; 2012 Feb 06; 80(2):459-64. PubMed ID: 22019529
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Bottom-Up and Top-Down Approaches to Explore Sodium Dodecyl Sulfate and Soluplus on the Crystallization Inhibition and Dissolution of Felodipine Extrudates.
    Chen J, Chen Y, Huang W, Wang H, Du Y, Xiong S.
    J Pharm Sci; 2018 Sep 06; 107(9):2366-2376. PubMed ID: 29738699
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Characterization of Supersaturated Danazol Solutions - Impact of Polymers on Solution Properties and Phase Transitions.
    Jackson MJ, Kestur US, Hussain MA, Taylor LS.
    Pharm Res; 2016 May 06; 33(5):1276-88. PubMed ID: 26892947
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.